We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iconic Labs Plc | LSE:ICON | London | Ordinary Share | GB00BRBJ3P08 | ORD GBP0.0001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Health & Allied Services,nec | 0 | 4.77M | 0.5697 | 0.09 | 418.58k |
TIDMICON
RNS Number : 3408A
Iconic Labs PLC
19 January 2024
19 January 2024
Iconic Labs PLC
("Iconic" or the "Company")
Notice of AGM
Iconic Labs PLC (LSE: ICON) announces that its Annual General Meeting ('AGM') will be held on Tuesday, 13 February 2024 at 12 noon at the offices of RWK Goodman, 69 Carter Lane, London, EC4V 5EQ.
The Notice of AGM has been posted to Shareholders and will be available to view shortly on the Company's website at: https://www.iconiclabs.co.uk/documents/ .
Amongst others, a special resolution at the AGM will be proposed seeking the approval of Shareholders to a share capital reorganisation.
For some time, the shares of the Company have been trading at below nominal value of GBP0.10. The issue of new ordinary shares in the Company at a price which is less than nominal value is prohibited by the UK Companies Act. The Board, therefore, considers it prudent to seek the approval of shareholders to a sub-division and conversion of each existing ordinary share of GBP0.10 ("Existing Ordinary Shares") into one new ordinary share of GBP0.0001 (a "New Ordinary Share") and one deferred share of GBP0.0999 (a "Deferred Share") (each such Deferred Share having no voting or dividend rights and effectively being worthless) in order that the nominal value of a New Ordinary Share is less than the price of a share in the market. This will enable the Company to raise funds in the future by issuing further shares, should the Directors elect to do so. By effecting this share capital reorganisation in this way, the Company's issued share capital remains the same and similarly, the nominal value of a Shareholder's shareholding will remain unchanged.
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
Publication and posting of the AGM Notice 19 January 2024 Latest time and date for receipt by Registrars 12 noon on 9 February of Form of Proxy in respect of the Annual 2024 General Meeting Annual General Meeting 12 noon on 13 February 2024 Record Date for the Share Capital Reorganisation 6.00 pm on 13 February 2024 Effective Date for the Share Capital Reorganisation 8.00 am on 14 February 2024
- Ends -
For more information, please contact:
Iconic Labs Tel: +44 (0) 7462 156238 Brad Taylor, Chief Executive Officer Novum Securities Limited Tel: +44 (0) 20 7399 9400 David Coffman / Daniel Harris Yellow Jersey PR Tel: +44 (0) 20 3004 9512 Sarah Hollins iconic@yellowjerseypr.com Annabelle Wills Bessie Elliot
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOAGPUMGGUPCGWB
(END) Dow Jones Newswires
January 19, 2024 10:49 ET (15:49 GMT)
1 Year Iconic Labs Chart |
1 Month Iconic Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions